Work

2-Oxoindolin-thiazoline hybrids as scaffold-based therapeutics for T2DM-associated cognitive impairment: design, synthesis, in vitro and in silico studies

Year: 2025
Type: article
Abstract: ADME profiling indicated desirable pharmacokinetic properties, further supporting the therapeutic potential of these compounds as dual-action agents for the management of Alzheimer's disease and type 2 diabetes mellitus.
Language: English
Field: Chemistry
Open Access status: green
OpenAlex ID: W4416210350
FWCI: 1.162
Cites: 35
Cited by: 4
Related to: